Kidney and urologic disease status update: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
(118 intermediate revisions by 7 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Organ System Project}} | |||
System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]''' | System leader: '''[[User:Maneesha Nandimandalam|Maneesha Nandimandalam, MD]]''' | ||
==Status Updates== | |||
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | |||
|+ | |||
! colspan="2" style="background:#efefef;" |Resident survival guide Progress | |||
|- | |||
|Completed | |||
|15 | |||
|- | |||
|In progress | |||
|6 | |||
|- | |||
|Remaining | |||
|3 | |||
|- | |||
! colspan="2" style="background:#efefef;" |Primary care chapter Progress | |||
|- | |||
|Completed | |||
|12 | |||
|- | |||
|In progress | |||
|6 | |||
|- | |||
|Remaining | |||
|5 | |||
|} | |||
== | ==Primary Care Topics== | ||
{| class="wikitable sortable" | |||
! colspan="4" |Primary care chapters | |||
! colspan="3" |Primary care resident survival guides | |||
|- | |||
!Specialty | |||
!Topic | |||
!Author | |||
!Status | |||
!Resident Survival Guide Page | |||
!Author | |||
!Status | |||
|- | |||
|Nephrology||[[Acute kidney injury]] | |||
|Farima kahe | |||
|Complete | |||
|[[Acute kidney failure resident survival guide]]||Kanwal Khmuani||Needs some review | |||
|- | |||
|Nephrology||[[Acidosis]] | |||
|Carlos | |||
|Needs review | |||
|[[Acidosis resident survival guide]]|| ||P | |||
|- | |||
|Nephrology||[[Alkalosis]] | |||
|Mydah | |||
|In progress | |||
|[[Alkalosis resident survival guide]]|| ||Needs content | |||
|- | |||
|Nephrology||[[Hyperkalemia]] | |||
|Jogeeth Singh | |||
|Complete | |||
|[[Hyperkalemia resident survival guide]]||Mahmoud||Complete | |||
|- | |||
|Nephrology||[[Hypokalemia]] | |||
|Cafer Zorkun | |||
|Needs some content | |||
|[[Hypokalemia resident survival guide]]|| ||Complete | |||
|- | |||
|Nephrology||[[Hypernatremia]] | |||
|Feham Tariq | |||
|Complete | |||
|[[Hypernatremia resident survival guide]]||Mounika (Ahmed's scholar)||Being reviewed | |||
|- | |||
|Nephrology||[[Hyponatremia]] | |||
| | |||
|Needs content | |||
|[[Hyponatremia resident survival guide]]||Priyamvada||Complete | |||
|- | |||
|Nephrology||[[Metabolic acidosis]] | |||
|Sidra Kalsoom | |||
|Needs review | |||
|[[Metabolic acidosis resident survival guide]]||Ogheneochuko||Complete | |||
|- | |||
|Nephrology||[[Metabolic alkalosis]] | |||
|Marufa Marium | |||
|Needs review | |||
|[[Metabolic alkalosis resident survival guide]]||Marufa Marium||Needs English Review | |||
|- | |||
|Nephrology||[[Respiratory acidosis]] | |||
|Nasrin | |||
|Assigned needs content | |||
|[[Respiratory acidosis resident survival guide]]||Qasim Khurshid||Needs English Review | |||
|- | |||
|Nephrology||[[Respiratory alkalosis]] | |||
| | |||
|Complete | |||
|[[Respiratory alkalosis resident survival guide]]||Rinky Agnes | |||
|Needs review | |||
|- | |||
|Nephrology||[[Nephrolithiasis]] | |||
|Amandeep Singh | |||
|Complete | |||
|[[Nephrolithiasis resident survival guide]]|| ||Complete | |||
|- | |||
|Nephrology | |||
|[[Nocturia]] | |||
|Sivakrishna Kumar, Nasrin | |||
|Needs Review | |||
|[[Nocturia resident survival guide]] | |||
|Sidra | |||
|In progress | |||
|- | |||
|Nephrology||[[Polyuria]] | |||
|Amandeep Singh | |||
|Complete | |||
|[[Polyuria resident survival guide]]||Zaida | |||
|In progress | |||
|- | |||
|Nephrology||[[Renal artery stenosis]] | |||
|Shivam Singla | |||
|Assigned | |||
|[[Renal artery stenosis resident survival guide]]||Karol||Complete | |||
|- | |||
|Nephrology | |||
|[[Hematuria]] | |||
|Sivakrishna Kumar | |||
|Needs review | |||
|[[Hematuria resident survival guide]] | |||
|Tayyaba Ali | |||
|Needs English review | |||
|- | |||
|Nephrology | |||
|[[Dysuria]] | |||
|Nabeel | |||
|In progress | |||
|[[Dysuria resident survival guide]] | |||
|Rinky | |||
|Complete | |||
|- | |||
|Nephrology | |||
|[[Flank pain]] | |||
|Samantha Salomun | |||
|In progress | |||
|[[Flank pain resident survival guide]] | |||
|Qasim Khurshid | |||
|Needs English review | |||
|- | |||
|Nephrology | |||
|[[Urinary tract infection]] | |||
|Usama Talib | |||
|Complete | |||
|[[Urinary tract infection resident survival guide]] | |||
| | |||
|Complete | |||
|- | |||
|Nephrology | |||
|[[Pyuria]] | |||
|Sadaf | |||
|Complete | |||
|[[Pyuria resident survival guide]] | |||
|Ibtisam Ashraf | |||
|Needs English Review | |||
|- | |||
|Nephrology | |||
|[[Hypertension]] | |||
|Usama Talib | |||
|Complete | |||
|[[Hypertension resident survival guide]] | |||
| | |||
|Complete | |||
|- | |||
|Nephrology | |||
|[[Edema generalized|Edema]] | |||
|Mydah | |||
|Complete | |||
|[[Edema resident survival guide]] | |||
|Sara zand | |||
|In progress | |||
|- | |||
|Nephrology | |||
|[[Urinary retention]] | |||
|Luke Orazem | |||
|Assigned(Sidra Kalsoom) | |||
|[[Urinary retention resident survival guide]] | |||
|Kanwal Khmuani | |||
|Needs English review | |||
|- | |||
|Nephrology | |||
|[[Urinary incontinence]] | |||
|Maneesha | |||
|In progress | |||
|[[Urinary incontinence resident survival guide]] | |||
|Maneesha | |||
|Complete | |||
|- | |||
|} | |||
==Status Update== | |||
{| class="wikitable" border="1" cellpadding="5" cellspacing="0" align="center" |class="wikitable" | |||
|+ | |||
! colspan="2" style="background:#efefef;" |Progress | |||
! | |||
|- | |- | ||
| rowspan=" | |Completed | ||
|35 | |||
|- | |||
|In progress | |||
|4 | |||
|- | |||
|Remaining | |||
|37 | |||
|} | |||
==List of Chapters Requiring Content== | |||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters that need content}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Coach name}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Completion Status}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Review status}} | |||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Reviewer name}} | |||
|- | |||
| rowspan="41" style="padding: 5px 5px; background: #DCDCDC; font-weight: bold;" |Kidney diseases | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 25: | Line 234: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Acute uric acid nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Albuminuria | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Balkan nephropathy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 34: | Line 261: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Bartter syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba Ali | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Huda | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Beer potomania | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Boyd-Stearns syndrome | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*[[Branchio-oto-renal syndrome]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Continuous veno-venous hemofiltration | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 70: | Line 306: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Calix diverticulum | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 79: | Line 315: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Contrast-induced acute kidney injury | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 88: | Line 324: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Cholesterol emboli syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Abdul | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed Elsaiey | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Crush syndrome | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Akash Hans | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Ahmed | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*C4 glomerulopathy | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |{{Norina Usman}} | |||
| style="padding: 5px 5px; background: #F5F5F5;" |{{ADG}} | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Dent's disease | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 104: | Line 358: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Dialysis (LP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 113: | Line 367: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Diuresis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 124: | Line 378: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Fibrillary immunotactoid glomerulopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 133: | Line 387: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Glomerulosclerosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 151: | Line 396: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Hypophosphatemia | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 160: | Line 405: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Haff disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Swathi Joshi | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Hemodialysis (SP) | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 168: | Line 422: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*Hypertensive nephropathy | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Kidney transplantation | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 177: | Line 439: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Multicystic dysplastic kidney | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 190: | Line 451: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Nephroptosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 200: | Line 461: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | *Nutcracker syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
|- | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
*[[Papillorenal syndrome]] | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Assigned | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Shivam Singla | |||
| style="padding: 5px 5px; background: #F5F5F5;" |Sara Mohsin | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 209: | Line 480: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Peritoneal dialysis (SP) | *Peritoneal dialysis (SP) | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 218: | Line 489: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Phosphate nephropathy | *Phosphate nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned | | style="padding: 5px 5px; background: #F5F5F5;" |Assingned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ | ||
Line 227: | Line 498: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Pyonephrosis | *Pyonephrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Harshwardan Chawla | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 236: | Line 507: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rhabdomyolysis | *Rhabdomyolysis | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Assingned | | style="padding: 5px 5px; background: #F5F5F5;" |Assingned | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ, | | style="padding: 5px 5px; background: #F5F5F5;" |Ayesha FJ, | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sogand | | style="padding: 5px 5px; background: #F5F5F5;" |Sogand | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 245: | Line 516: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Rebound diuresis | *Rebound diuresis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 255: | Line 526: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Renal agenesis | *Renal agenesis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Shakiba | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Renal artery stenosis | *Renal artery stenosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 272: | Line 543: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Renal papillary necrosis | *Renal papillary necrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Nasrin | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 282: | Line 553: | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
* Thin basement membrane disease | *Thin basement membrane disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Marufa Marium | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Maneesha | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
Line 315: | Line 586: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Analgesic nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Shakiba | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |HIV associated nephropathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Shakiba | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Milk-alkali syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Shakiba | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Elsaiey,Ahmed | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Bartter syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Assigned | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Tayyaba | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Huda | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Not done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
Line 509: | Line 780: | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Category}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Chapters}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Assignment Status}} | ||
! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}} | ! rowspan="1" style="background: #4479BA; padding: 5px 5px;" |{{fontcolor|#FFFFFF|Scholar's name}} | ||
Line 582: | Line 853: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Farima | | style="padding: 5px 5px; background: #F5F5F5;" |Farima | ||
|- | |- | ||
Line 591: | Line 862: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aida/ Omer | | style="padding: 5px 5px; background: #F5F5F5;" |Aida/ Omer | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Iqra | | style="padding: 5px 5px; background: #F5F5F5;" |Iqra | ||
|- | |- | ||
Line 600: | Line 871: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Nazia / Jogeet | | style="padding: 5px 5px; background: #F5F5F5;" |Nazia / Jogeet | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
|- | |- | ||
Line 609: | Line 880: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sunny/ Seyd | | style="padding: 5px 5px; background: #F5F5F5;" |Sunny/ Seyd | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep | | style="padding: 5px 5px; background: #F5F5F5;" |Amandeep | ||
|- | |- | ||
Line 618: | Line 889: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |rc Arash | | style="padding: 5px 5px; background: #F5F5F5;" |rc Arash | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
|- | |- | ||
Line 627: | Line 898: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar | | style="padding: 5px 5px; background: #F5F5F5;" |Dildar | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
|- | |- | ||
|- | |- | ||
Line 636: | Line 907: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Akshun | | style="padding: 5px 5px; background: #F5F5F5;" |Akshun | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Farima | | style="padding: 5px 5px; background: #F5F5F5;" |Farima | ||
|- | |- | ||
Line 645: | Line 916: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Shamila | | style="padding: 5px 5px; background: #F5F5F5;" |Shamila | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
|- | |- | ||
Line 712: | Line 983: | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |C3 glomerulopathy | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Vindhya | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Bladder cancer | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Farima Kahe | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis | | style="padding: 5px 5px; background: #F5F5F5;" |Hydronephrosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Chandra | | style="padding: 5px 5px; background: #F5F5F5;" |Chandra | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
|- | |- | ||
Line 740: | Line 1,011: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Amandeep | | style="padding: 5px 5px; background: #F5F5F5;" |Amandeep | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Polycystic kidney disease | | style="padding: 5px 5px; background: #F5F5F5;" |Polycystic kidney disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Khurram | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Anmol | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Nephritic syndrome | | style="padding: 5px 5px; background: #F5F5F5;" |Nephritic syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Dildar | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Nephrotic syndrome | | style="padding: 5px 5px; background: #F5F5F5;" |Nephrotic syndrome | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Sadaf | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Post-streptococcal glomerulonephritis | | style="padding: 5px 5px; background: #F5F5F5;" |Post-streptococcal glomerulonephritis | ||
Line 772: | Line 1,043: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Manpreet | | style="padding: 5px 5px; background: #F5F5F5;" |Manpreet | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | | style="padding: 5px 5px; background: #F5F5F5;" |Mehrian | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Renal cell carcinoma | | style="padding: 5px 5px; background: #F5F5F5;" |Renal cell carcinoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Farima | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Anmol | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Renal osteodystrophy | | style="padding: 5px 5px; background: #F5F5F5;" |Renal osteodystrophy | ||
Line 796: | Line 1,067: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Aditya | | style="padding: 5px 5px; background: #F5F5F5;" |Aditya | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun | | style="padding: 5px 5px; background: #F5F5F5;" |Sargun | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Renal vein thrombosis | | style="padding: 5px 5px; background: #F5F5F5;" |Renal vein thrombosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Saeedeh | |||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Mehdi | ||
|- | |- | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Wilms' tumor | | style="padding: 5px 5px; background: #F5F5F5;" |Wilms' tumor | ||
Line 812: | Line 1,083: | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Sargun | | style="padding: 5px 5px; background: #F5F5F5;" |Sargun | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Yes | ||
| style="padding: 5px 5px; background: #F5F5F5;" | | | style="padding: 5px 5px; background: #F5F5F5;" |Done | ||
| style="padding: 5px 5px; background: #F5F5F5;" |Farima | | style="padding: 5px 5px; background: #F5F5F5;" |Farima | ||
|- | |- | ||
|} | |} |
Latest revision as of 17:45, 25 May 2021
Organ System Project |
---|
Topics |
Leaders & Members |
Meetings' Summary |
System leader: Maneesha Nandimandalam, MD
Status Updates
Resident survival guide Progress | |
---|---|
Completed | 15 |
In progress | 6 |
Remaining | 3 |
Primary care chapter Progress | |
Completed | 12 |
In progress | 6 |
Remaining | 5 |
Primary Care Topics
Primary care chapters | Primary care resident survival guides | |||||
---|---|---|---|---|---|---|
Specialty | Topic | Author | Status | Resident Survival Guide Page | Author | Status |
Nephrology | Acute kidney injury | Farima kahe | Complete | Acute kidney failure resident survival guide | Kanwal Khmuani | Needs some review |
Nephrology | Acidosis | Carlos | Needs review | Acidosis resident survival guide | P | |
Nephrology | Alkalosis | Mydah | In progress | Alkalosis resident survival guide | Needs content | |
Nephrology | Hyperkalemia | Jogeeth Singh | Complete | Hyperkalemia resident survival guide | Mahmoud | Complete |
Nephrology | Hypokalemia | Cafer Zorkun | Needs some content | Hypokalemia resident survival guide | Complete | |
Nephrology | Hypernatremia | Feham Tariq | Complete | Hypernatremia resident survival guide | Mounika (Ahmed's scholar) | Being reviewed |
Nephrology | Hyponatremia | Needs content | Hyponatremia resident survival guide | Priyamvada | Complete | |
Nephrology | Metabolic acidosis | Sidra Kalsoom | Needs review | Metabolic acidosis resident survival guide | Ogheneochuko | Complete |
Nephrology | Metabolic alkalosis | Marufa Marium | Needs review | Metabolic alkalosis resident survival guide | Marufa Marium | Needs English Review |
Nephrology | Respiratory acidosis | Nasrin | Assigned needs content | Respiratory acidosis resident survival guide | Qasim Khurshid | Needs English Review |
Nephrology | Respiratory alkalosis | Complete | Respiratory alkalosis resident survival guide | Rinky Agnes | Needs review | |
Nephrology | Nephrolithiasis | Amandeep Singh | Complete | Nephrolithiasis resident survival guide | Complete | |
Nephrology | Nocturia | Sivakrishna Kumar, Nasrin | Needs Review | Nocturia resident survival guide | Sidra | In progress |
Nephrology | Polyuria | Amandeep Singh | Complete | Polyuria resident survival guide | Zaida | In progress |
Nephrology | Renal artery stenosis | Shivam Singla | Assigned | Renal artery stenosis resident survival guide | Karol | Complete |
Nephrology | Hematuria | Sivakrishna Kumar | Needs review | Hematuria resident survival guide | Tayyaba Ali | Needs English review |
Nephrology | Dysuria | Nabeel | In progress | Dysuria resident survival guide | Rinky | Complete |
Nephrology | Flank pain | Samantha Salomun | In progress | Flank pain resident survival guide | Qasim Khurshid | Needs English review |
Nephrology | Urinary tract infection | Usama Talib | Complete | Urinary tract infection resident survival guide | Complete | |
Nephrology | Pyuria | Sadaf | Complete | Pyuria resident survival guide | Ibtisam Ashraf | Needs English Review |
Nephrology | Hypertension | Usama Talib | Complete | Hypertension resident survival guide | Complete | |
Nephrology | Edema | Mydah | Complete | Edema resident survival guide | Sara zand | In progress |
Nephrology | Urinary retention | Luke Orazem | Assigned(Sidra Kalsoom) | Urinary retention resident survival guide | Kanwal Khmuani | Needs English review |
Nephrology | Urinary incontinence | Maneesha | In progress | Urinary incontinence resident survival guide | Maneesha | Complete |
Status Update
Progress | |
---|---|
Completed | 35 |
In progress | 4 |
Remaining | 37 |
List of Chapters Requiring Content
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | |||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Tayyaba Ali | Huda | ||||
|
|||||||
|
|||||||
Assigned | Shivam Singla | Sara Mohsin | |||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Abdul | Ahmed Elsaiey | ||||
|
Assigned | Akash Hans | Ahmed | ||||
|
Assigned | Norina Usman, M.B.B.S[1] | Aditya Ganti M.B.B.S. [2] | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
|
Assigned | Swathi Joshi | |||||
|
|||||||
|
Assigned | Nasrin | Elsaiey,Ahmed | ||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
Assigned | Shivam Singla | Sara Mohsin | |||||
|
|||||||
|
Assingned | Ayesha FJ | Sogand | ||||
|
Assigned | Harshwardan Chawla | Aditya | ||||
|
Assingned | Ayesha FJ, | Sogand | ||||
|
|||||||
|
Assigned | Shakiba | Elsaiey,Ahmed | ||||
|
|||||||
|
Assigned | Nasrin | Elsaiey,Ahmed | ||||
|
Assigned | Marufa Marium | Maneesha |
In progress chapters
Category | Chapters that need content | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | Cardiorenal syndrome | Assigned | Dina | Huda | |||
Analgesic nephropathy | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
HIV associated nephropathy | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
Milk-alkali syndrome | Assigned | Shakiba | Elsaiey,Ahmed | Yes | Not done | ||
Bartter syndrome | Assigned | Tayyaba | Huda | Yes | Not done | ||
Completed chapters
Category | Chapters | Assignment Status | Scholar's name | Coach name | Completion Status | Review status | Reviewer name |
---|---|---|---|---|---|---|---|
Kidney diseases | Electrolyte imbalance (LP) | Mehdi | Yes | Done | Mehrian | ||
Hyponatremia | Saeedeh | Yes | Done | Mahshid | |||
Hypernatremia | Feham | Yes | Done | Elsaiey | |||
Hypokalemia | Rc-Aida | Yes | Done | Mahshid | |||
Hyperkalemia | Jogeet | Yes | Done | Amandeep | |||
Hypocalcemia | Krishna | Yes | Done | Hasan | |||
Hypercalcemia | Anmol | Yes | Done | Sudarshana Datta | |||
Glomerular Disease(LP) | Mehrian | Yes | Done | Farima | |||
Lupus Nephritis | Aida/ Omer | Yes | Done | Iqra | |||
Rapidly progressive glomerulonephritis | Nazia / Jogeet | Yes | Done | Aditya | |||
Membranous glomerulonephritis | Sunny/ Seyd | Yes | Done | Amandeep | |||
Membranoproliferative glomerulonephritis | rc Arash | Yes | Done | Aditya | |||
IgA nephropathy | Dildar | Yes | Done | Mehrian | |||
Goodpasture syndrome | Akshun | Yes | Done | Farima | |||
Amyloidosis (LP) | Shamila | Yes | Done | Mehrian | |||
Primary amyloidosis | |||||||
Secondary amyloidosis | |||||||
Familial amyloidosis | |||||||
Wild-type(senile) amyloidosis | |||||||
Cardiac amyloidosis | |||||||
Beta-2 microglobulin related amyloidosis | |||||||
Gelsolin related amyloidosis | |||||||
C3 glomerulopathy | Vindhya | Yes | Done | ||||
Bladder cancer | Farima Kahe | Yes | Done | ||||
Hydronephrosis | Chandra | Yes | Done | Aditya | |||
Kidney stone | Amandeep | Yes | Done | Aditya | |||
Polycystic kidney disease | Khurram | Yes | Done | Anmol | |||
Nephritic syndrome | Dildar | Yes | Done | Mehrian | |||
Nephrotic syndrome | Mehrian | Yes | Done | Sadaf | |||
Post-streptococcal glomerulonephritis | Manpreet | Yes | Done | Mehrian | |||
Renal cell carcinoma | Farima | Yes | Done | Anmol | |||
Renal osteodystrophy | |||||||
Renal tubular acidosis | Aditya | Yes | Done | Sargun | |||
Renal vein thrombosis | Saeedeh | Yes | Done | Mehdi | |||
Wilms' tumor | Sargun | Yes | Done | Farima |